Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Total Debt (2022 - 2024)

Neuraxis (NRXS) posted Total Debt of $38797.0 for Q2 2024, down 73.8% sequentially from $148062.0 in Q4 2023, and little changed YoY from $38797.0 in Q3 2023.

Neuraxis (NRXS) Total Debt (2022 - 2024) Analysis & Trends

Neuraxis has reported Total Debt for 3 years, with the latest figure at $38797.0 in Q2 2024.

  • Quarterly Total Debt changed 0.0% year-over-year to $38797.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $38797.0 (changed 0.0% YoY) and the FY2023 annual result came in at $148062.0, down 27.0% from the prior year.
  • Total Debt declined to $38797.0 in Q2 2024 per NRXS's latest filing, from $148062.0 in the prior quarter.
  • Over five years, Total Debt peaked at $2.6 million in Q1 2023 and troughed at $38797.0 in Q2 2023.
  • A 3-year average of $545456.3 and a median of $171155.0 in 2023 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2023 and 2024: Total Debt fell 27.0% in 2023, then changed 0.0% in 2024.
  • Over 3 years, Total Debt stood at $202834.0 in 2022, then retreated by 27.0% to $148062.0 in 2023, then sank by 73.8% to $38797.0 in 2024.
  • According to Business Quant data, Total Debt over the past three periods registered $38797.0, $148062.0, and $194248.0 for Q2 2024, Q4 2023, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 770.36 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.34 Bn
10 Neuraxis 74.54 Mn 66.21 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 38,797.00
Dec 31, 2023 148,062.00
Sep 30, 2023 194,248.00
Jun 30, 2023 38,797.00
Mar 31, 2023 2.65 Mn
Dec 31, 2022 202,834.00